“…3 These phthalimide catalysts (8a and 8b) displayed considerable enantioselectivity (up to 46% ee) and several related complexes were later prepared to include tert-leucinate [Rh 2 (S-PTTL) 4 ] 8e, valine [Rh 2 (S-PTV) 4 ] 8d, phenylglycine [Rh 2 (S-PTPG) 4 ] 8c and triethylalanine [Rh 2 (S-PTTEA) 4 ] 8f derived catalysts ( Figure 5), showing improvements in enantiocontrol in many cases, due to the increased steric bulk of the alkyl group of the ligand. 53,54 The related catalysts Rh 2 (S-NPV) 4 9a and Rh 2 (S-NPTL) 4 9b ( Figure 5) have also been developed by Chiu and co-workers, showing moderate enantioselectivity in the C-H insertion reactions of meso oxabicyclic compounds. Subsequent work by Hashimoto and co-workers has included the development of a series of catalysts featuring an extended phthalimido wall (Figure 6), namely, Rh 2 (S-BPTTL) 4 10d, Rh 2 (S-BPTA) 4 10a, Rh 2 (S-BPTPA) 4 10c, and Rh 2 (S-BPTV) 4 10b, derived from tert-leucine, alanine, phenylalanine, and valine, respectively.…”